Canmax Technologies Co

Canmax Technologies Co CROIC

The Cash Return on Invested Capital (CROIC) of Canmax Technologies Co (300390.SZ) as of Oct 23, 2026 is -31.23 %. In the previous year, Cash Return on Invested Capital (CROIC) was 5.76 % — a change of -641.89% (lower).

CROIC

-31.23 %

YoY

-641.89%

Last updated:

Cash Return on Invested Capital (CROIC) of Canmax Technologies Co is 2025 -31.23 % . Cash Return on Invested Capital (CROIC) of Canmax Technologies Co was 2024 5.76 % . It decreases by -641.89% lower compared to the previous year.

The Canmax Technologies Co CROIC history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CROIC
Date
CROIC
Jan 1, 2018
7.39 CNY
Jan 1, 2019
7.96 CNY
Jan 1, 2020
14.68 CNY
Jan 1, 2021
-13.54 CNY
Jan 1, 2022
29.76 CNY
Jan 1, 2023
12.34 CNY
Jan 1, 2024
5.76 CNY
Jan 1, 2025
-31.23 CNY
The Canmax Technologies Co CROIC history
YEARCROICYoY
-31.23 %-641.89%
5.76 %-53.29%
12.34 %-58.53%
29.76 %-319.70%
-13.54 %-192.27%
14.68 %+84.30%
7.96 %+7.76%
7.39 %+65.32%
4.47 %-200.96%
-4.43 %+25.62%
-3.53 %-978.44%
0.40 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Canmax Technologies Co Stock analysis

What does Canmax Technologies Co do? Canmax Technologies Co., Ltd. generates revenue through three core business segments. The Anti-static Ultra-clean Product segment sells human body protection systems, process protection systems, and environmental protection systems for cleanroom and ESD control. The Medical Device Product segment offers self-destruction syringes, safety syringes, and high pressure syringes. The Lithium Battery Material Product segment focuses on battery-grade lithium hydroxide, covering R&D, production, and sales. Domestic and overseas markets are the primary sales channels for all product lines. The company's customers include manufacturers requiring cleanroom solutions, healthcare providers needing medical devices, and battery producers seeking lithium hydroxide. These segments serve distinct industries: cleanroom and ESD control for electronics manufacturing, medical devices for healthcare, and battery materials for energy storage. The firm's product portfolio targets specific industrial needs within these sectors. Revenue streams are derived from the sale of anti-static ultra-clean products, medical devices, and lithium hydroxide. The Anti-static Ultra-clean Product segment supports electronics manufacturing with specialized systems, while the Medical Device Product segment caters to healthcare safety standards. The Lithium Battery Material Product segment meets demand for battery-grade lithium hydroxide in the growing energy storage market. Canmax Technologies Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Canmax Technologies Co stock

Cash Return on Invested Capital (CROIC) of Canmax Technologies Co is -31.23 % in 2025.

Cash Return on Invested Capital (CROIC) of Canmax Technologies Co changed from 5.76 % to -31.23 %, representing a -641.89% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Cash Return on Invested Capital (CROIC) Canmax Technologies Co since 2006 – with annual values, charts, and detailed analysis.

CROIC measures the cash return generated on invested capital. Unlike ROIC, it uses free cash flow instead of accounting earnings, providing a purer profitability measure.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Return on Invested Capital (CROIC)'s Canmax Technologies Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Return on Invested Capital (CROIC)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Return on Invested Capital (CROIC).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Canmax Technologies Co

All Key Metrics — Canmax Technologies Co